Anna Nordmark

Director Drug Development

When Anna joined SDS in 2018, she brought six years’ experience as a Clinical Pharmacology Assessor at the Swedish Medical Products Agency (MPA), in addition to nine years at Astra Zeneca as a DMPK Project Leader and as a Clinical Pharmacology Scientist. As a regulator, Anna has actively contributed to the development of new guidelines as well as participated in harmonisation discussions with other agencies. Anna’s holds a MSc in Pharmacy and a PhD in Clinical Pharmacology from Karolinska Institutet, Sweden.

Anna is a Senior Advisor of Regulatory Affairs and Clinical Pharmacology at SDS. She guides clients through their nonclinical, DMPK, Clinical pharmacology and Clinical development projects both from a scientific and a regulatory perspective.

Contact details
+ 46 70 508 89 22